TF
CRL icon

Tompkins Financial’s Charles River Laboratories CRL Stock Holding History

Tompkins Financial’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-122
Closed -$18K – 359
2019
Q1 		$18K Hold
122
– – ﹤0.01% 314
2018
Q4 		$14K Sell
122
-77
-39% -$9.64K ﹤0.01% 318
2018
Q3 		$27K Sell
199
-86
-30% -$10.6K 0.01% 295
2018
Q2 		$32K Hold
285
– – 0.01% 292
2018
Q1 		$30K Buy
+285
New +$30.7K 0.01% 284
2017
Q4 		– Sell
-45
Closed -$5K – 402
2017
Q3 		$5K Buy
+45
New +$4.62K ﹤0.01% 363

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return